BURLINGTON, North Carolina -- LabCorp has received emergency use authorization from the Food and Drug Administration for its Pixel at home coronavirus test kit. The COVID-19 At Home Test Kit allows ...

BURLINGTON, N.C. (WJZY) — North Carolina-based LabCorp announced Tuesday that it has received an Emergency Use Authorization from the U.S. Food and Drug Administration for at-home COVID-19 test kits.

The FDA has authorized the first diagnostic test with a home collection option for COVID-19, the disease caused by coronavirus. In a statement released Tuesday, the FDA said that it had reissued an ...

(NEW YORK) — As COVID-19 test positivity rates resurged in recent weeks, private test providers have made efforts to sound the alarm that the rising demand for testing may outpace their ability to ...

As a leading independent diagnostic laboratory, LabCorp participates in a highly attractive duopoly that offers bright prospects as healthcare moves toward reformed payment models, despite current ...

North Carolina’s LabCorp has gotten the federal go-ahead for an at-home testing kit for COVID-19, the new coronavirus. It’s the first authorized by the Food and Drug Administration. LabCorp of ...

Labcorp (NYSE:LH) posted its fourth consecutive quarterly revenue decline on Thursday, estimating up to a 90% decline in its COVID testing revenue this year amid the waning pandemic impact. However, ...

(Reuters) -Laboratory Corp of America Holdings on Thursday predicted that COVID testing sales could fall by up to 90% this year after nearly two years of a boost to its diagnostics unit during the ...

Laboratory Corporation of America Holdings or Labcorp LH is entangled in the current economic uncertainty due to a challenging volume environment for testing laboratories and utilization weaknesses.

Shares of Laboratory Corporation of America Holdings LH were down about 2.9% in premarket trading on Thursday after the diagnostics company reported lower-than-expected revenue in the fourth quarter ...